Helius Medical Technologies

Neurotech company (Nasdaq: HSDT)

Helius Medical Technologiesについて

設立2014

Helius is a leading neurotechnology company in the medical device field, specializing in utilizing non-implantable platform technologies to treat neurological deficits, enhance the brain's compensatory abilities, and promote neuroplasticity, thereby improving the lives of patients with neurological disorders. The company has announced the establishment of the SOL Treasury.

コミュニティ
LinkedIn
Website
タグ
Publicly listed company
Crypto Stocks

ホットインデックス変動トレンド

チームメンバー

Dane C. Andreeff
Dane C. Andreeff

President and Chief Executive Officer

Jeffrey S. Mathiesen
Jeffrey S. Mathiesen

Chief Financial Officer

投資家

Pantera Capital
Pantera Capital
Summer Capital
Summer Capital

資金調達の詳細

Post-IPO(2025-09-14)
金額¥79.50B
投資家
Pantera Capital
Pantera Capital
Summer Capital
Summer Capital
評価額--